Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Mount Carmel: Medication for  all Generations Commonly  Prescribed  Medicine that Promotes Mental Health
“Psychiatric Medication”  <ul><li>Medication groups
Indications, Benefits and Risks
Realistic expectations
How use and misuse of medication can affect our clientele </li></ul>
Agenda <ul><li>Depression, Bipolar Disease, Anxiety, Insomnia, OCD, ADDH, Social Phobia, Drugs Used to Treat Addiction Wit...
Every person is individual
Each person plays an essential role in our community </li></ul>
Stigma of Mental Health Issues  <ul><li>Medication is only one piece, it is not the answer
Each person uses the treatment modality he or she finds the most helpful  </li></ul>
Vocabulary <ul><li>Indication, Risk Factors, Mechanism of Action, Adverse Effects, Pharmacokinetics, Pharmacodynamics, Thy...
Synapse, Neural Plate, Neural Signalling Pathways, Action Potential, Inhibitory and Excitatory Nerve Pathways
Pharmaceutical Companies, Generics and Me Too’s </li></ul>
Neuronal Synapse
Neural Communication <ul><li>Combination of electrical firing (depole) and chemical signaling
Intensity of neurotransmitter release and binding to post-synaptic sites opens voltage gated sodium channels
Resting membrane potential is affected and an action potential can result (electric signal) that travels down the axon
Neurotransmitter is released from sites and
re-uptake occurs  </li></ul>
 
Upcoming SlideShare
Loading in …5
×

Pharm psych med for social workers

june 23 meeting with social workers group

  • Login to see the comments

Pharm psych med for social workers

  1. 1. Mount Carmel: Medication for all Generations Commonly Prescribed Medicine that Promotes Mental Health
  2. 2. “Psychiatric Medication” <ul><li>Medication groups
  3. 3. Indications, Benefits and Risks
  4. 4. Realistic expectations
  5. 5. How use and misuse of medication can affect our clientele </li></ul>
  6. 6. Agenda <ul><li>Depression, Bipolar Disease, Anxiety, Insomnia, OCD, ADDH, Social Phobia, Drugs Used to Treat Addiction Withdrawal, Schizophrenia etc.
  7. 7. Every person is individual
  8. 8. Each person plays an essential role in our community </li></ul>
  9. 9. Stigma of Mental Health Issues <ul><li>Medication is only one piece, it is not the answer
  10. 10. Each person uses the treatment modality he or she finds the most helpful </li></ul>
  11. 11. Vocabulary <ul><li>Indication, Risk Factors, Mechanism of Action, Adverse Effects, Pharmacokinetics, Pharmacodynamics, Thymoleptics, Neuroleptics.
  12. 12. Synapse, Neural Plate, Neural Signalling Pathways, Action Potential, Inhibitory and Excitatory Nerve Pathways
  13. 13. Pharmaceutical Companies, Generics and Me Too’s </li></ul>
  14. 14. Neuronal Synapse
  15. 15. Neural Communication <ul><li>Combination of electrical firing (depole) and chemical signaling
  16. 16. Intensity of neurotransmitter release and binding to post-synaptic sites opens voltage gated sodium channels
  17. 17. Resting membrane potential is affected and an action potential can result (electric signal) that travels down the axon
  18. 18. Neurotransmitter is released from sites and
  19. 19. re-uptake occurs </li></ul>
  20. 21. Antidepressants <ul><li>Older types: tricyclics, ssri’s
  21. 22. Mixed type and evolved ssri's etc
  22. 23. What does a depressed person look like:
  23. 24. What can they expect to feel on these medications? </li></ul>
  24. 25. <ul><li>Buproprion
  25. 26. Venlafaxine
  26. 27. Mirtazepine
  27. 28. Trazodone (ssri)
  28. 29. Research suggests too many clients are maintained on too small dose and have incomplete relief and still have the side effects. Once treatment is satisfactory, pt should stay on 6 months. </li></ul>Anitidepressants
  29. 30. Antipsychotics <ul><li>Older types: first generation
  30. 31. Risperidone, olanzapine, melt in your mouth etc.
  31. 32. Effects of stress and low dose antipsychotics on prodromal symptoms (PIER)
  32. 33. What does prodrome (premonitory symptoms) look like?
  33. 34. What can they expect to feel like on these meds? </li></ul>
  34. 35. Schizophrenia <ul><li>Avolition(lack of initiative, motivation)
  35. 36. Flat affect (withdrawal, poor hygiene)
  36. 37. Perception disturbance (hallucination)
  37. 38. Delusions
  38. 39. Disorganized or catatonic behaviour
  39. 40. Impaired social and occupational function
  40. 41. Disorganized speech
  41. 42. Decreased processes in thought or speech (slowed cognition) </li></ul>
  42. 43. Benzodiazepines <ul><li>Old types, history of barbitals and valium
  43. 44. Safer benzodiazepines and buspar
  44. 45. How can anxiety mar your life and stifle your participation in society?
  45. 46. panic disorder, ocd
  46. 47. How will they feel on this med?
  47. 48. Why is this family dangerous?
  48. 49. Sleep aids and sleep architechture </li></ul>
  49. 50. Mood Stabilizers <ul><li>Good old lithium and carbamazepine
  50. 51. The irritation and joy of serum levels
  51. 52. New indications for antipsychotics
  52. 53. Why don’t they want treatment?
  53. 54. Types of bipolar
  54. 55. What can the patient expect to happen after starting these medications? </li></ul>
  55. 56. Mood Stabilizers <ul><li>Lithium
  56. 57. Valproic acid
  57. 58. Carbamazapine
  58. 59. Olanzapine
  59. 60. Omega 3 fatty acid
  60. 61. lamotrigine </li></ul>
  61. 62. Bipolar Disorder <ul><li>Monoamine theory excess norepinephrine and dopamine alternates with low levels along with low serotonin
  62. 63. Permissive theory excess norepinephrine and serotonin with low levels
  63. 64. G-protein that regulates appetite,wakefulness and mood. Controls sodium and potassium cation channels
  64. 65. G-protein is hyperactive intracellular 2 nd messenger regulator
  65. 66. Lithium and epival down regulate protein kinase c activity </li></ul>
  66. 67. Bipolar Disorder <ul><li>Presents in adulthood, usually after years without diagnosis (genetic)
  67. 68. Time between cycles usually lengthen over time (maintain euthymia)
  68. 69. Important to avoid episodes which cause brain changes and resistance to medications
  69. 70. Treated with lithium, antiepileptics (carbamazepine and valproic acid), atypical antipsychotics and antidepressants </li></ul>
  70. 71. In Closing “Pearls” <ul><li>Brief description of “drug families” and nomenclature
  71. 72. Drug interactions galore
  72. 73. Pharmacy Perspective, Family issues, Pts going into detox, instilling hope and mastery
  73. 74. Legal and Ethical Issues for Pharmacists: the rules around addictive meds or drugs of abuse
  74. 75. The crazy expense of new meds and how samples defeat the purpose sometimes
  75. 76. How psychiatrists prescribe vs family doctors
  76. 77. How do families, co-workers, and friends react to “treatment”
  77. 78. Daily observed treatment, how the pharmacist is dispensing rounds in the community </li></ul>
  78. 79. Adherence & Patience
  79. 80. Where to Get More Information <ul><li>Online and anecdotal data can be confusing or just wrong.
  80. 81. “Up to date online”
  81. 82. Ask the patient what they understand about their medication. In what ways does it assist his or her functioning? In what ways does it diminish functioning/ </li></ul>

×